Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...
We are at a turning point in the fight against Alzheimer’s disease with the emergence of disease-modifying therapies for ...
SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...
A new study provides important insight into how amyloid-beta and tau proteins impact brain activity and possibly contribute to cognitive decline in Alzheimer's disease.
Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...
For years, many people with Alzheimer's disease have been diagnosed clinically and confirmed at autopsy. Now Alzheimer's ...
Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.
Carmen A. Guzman, 75, was reported missing on Sept. 19 when he was last seen with family at Hardee’s restaurant, 913 E. Main ...
There's no single test that can tell when someone has Alzheimer's disease. Identifying the disease in the early stages allows ...
Optimizing iPSC differentiation significantly improves in vitro Alzheimer's disease models, leading to more accurate and ...
On Sep. 22, 2024 the St. Joe Frontier Casino and the Alzheimer's Association held their annual Walk to End Alzheimer's.